Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

10,869 total articles

Philips launches new Bridge Plus Occlusion Balloon to help manage rare but life-threatening SVC tears during lead extraction

Philips launches new Bridge Plus Occlusion Balloon to help manage rare but life-threatening SVC tears during lead extraction

Royal Philips has introduced the Bridge Plus Occlusion Balloon, an advanced medical device designed to rapidly manage life-threatening superior vena cava tears during cardiac lead extraction procedures. Building on proven technology, this device enables quick deployment to control bleeding and stabilize patients, potentially improving survival rate…

NYSE: MMA Reports Record Q1 BJJLink Activity As Student Check-ins Surpass 1.42 million Since Inception

NYSE: MMA Reports Record Q1 BJJLink Activity As Student Check-ins Surpass 1.42 million Since Inception

Mixed Martial Arts Group Limited (NYSE American: MMA) announced a record 216,176 Brazilian Jiu-Jitsu (BJJ) student check-ins on its BJJLink platform in Q1 2026, representing a 105% year-over-year increase and a 6.3x growth since Q1 2023. The platform has accumulated over 1.42 million total check-ins, providing valuable behavioral data supporting re…

Fusion Fuel Appoints Uranium Investor James Passin as Chairman and Appoints Frederico Figueira de Chaves as Chief Executive Officer

Fusion Fuel Appoints Uranium Investor James Passin as Chairman and Appoints Frederico Figueira de Chaves as Chief Executive Officer

Fusion Fuel Green PLC announced key leadership changes with the appointment of James Passin, an institutional uranium investment expert, as Chairman and Frederico Figueira de Chaves as Chief Executive Officer. This leadership shift aligns with the company's strategic focus on expanding its uranium royalty platform and exploring growth opportunities…

Kearny Financial Corp. Announces Third Quarter Fiscal 2026 Results and Declaration of Cash Dividend

Kearny Financial Corp. Announces Third Quarter Fiscal 2026 Results and Declaration of Cash Dividend

Kearny Financial Corp., the holding company of Kearny Bank, announced net income of $10.1 million ($0.16 per diluted share) for Q3 fiscal 2026, up from $9.4 million in the previous quarter. The company experienced its sixth consecutive quarter of net interest margin expansion, growing net interest income by 3%. The Board declared a quarterly cash d…

TowneBank Announces Special Cash Dividend

TowneBank Announces Special Cash Dividend

TowneBank announced a special one-time cash dividend of $0.70 per share payable in May 2026, distributing approximately $65 million to shareholders. This dividend is funded by gains from the recent $250 million sale of its Resort Property Management business, reflecting the success of the company's strategy to create shareholder value through diver…

Polaryx Therapeutics to Participate in National Tay-Sachs & Allied Diseases Association Annual Family Conference

Polaryx Therapeutics to Participate in National Tay-Sachs & Allied Diseases Association Annual Family Conference

Polaryx Therapeutics announced its participation in the National Tay-Sachs & Allied Diseases Association Annual Family Conference to connect with patients and advocates while advancing its lead drug candidate, PLX-200, through the upcoming SOTERIA Phase 2 basket trial. This trial will evaluate PLX-200's safety and efficacy across several rare lysos…

RenovoRx Announces Pharmacokinetic and Pharmacodynamic Data Abstract Supporting the TAMP™ Therapy Platform Accepted for Presentation at the 2026 ASCO Annual Meeting

RenovoRx Announces Pharmacokinetic and Pharmacodynamic Data Abstract Supporting the TAMP™ Therapy Platform Accepted for Presentation at the 2026 ASCO Annual Meeting

RenovoRx, Inc. announced that pharmacokinetic and pharmacodynamic data from its Phase III TIGeR-PaC clinical trial, studying intra-arterial gemcitabine delivery via its RenovoCath device versus intravenous gemcitabine for locally advanced pancreatic cancer, has been accepted for presentation at the 2026 American Society of Clinical Oncology (ASCO) …

Vericel to Report First-Quarter 2026 Financial Results on May 7, 2026

Vericel to Report First-Quarter 2026 Financial Results on May 7, 2026

Vericel Corporation announced that it will report its first-quarter 2026 financial results on May 7, 2026. The company will hold a conference call and webcast to discuss the financial results and business highlights. Vericel specializes in advanced therapies for sports medicine and severe burn care, marketing three main products in the United State…

Barnes & Noble Education to Host Investor Day on June 25, 2026

Barnes & Noble Education to Host Investor Day on June 25, 2026

Barnes & Noble Education, Inc. announced it will host a virtual Investor Day on June 25, 2026, to present the company's strategy, growth drivers, and financial outlook. The leadership will focus on expanding the First Day® programs, enhancing the omnichannel campus retail model, scaling academic solutions, and improving operational efficiencies. Th…

West Bancorporation, Inc. Announces First Quarter 2026 Financial Results And Declares Quarterly Dividend

West Bancorporation, Inc. Announces First Quarter 2026 Financial Results And Declares Quarterly Dividend

West Bancorporation, Inc. (NASDAQ: WTBA) announced robust first quarter 2026 financial results, reporting net income of $10.6 million, a 34.8% increase year-over-year, and declared a quarterly dividend of $0.25 per share. The company's net interest margin improved to 2.59%, supported by a decrease in deposit costs. West Bancorporation’s balance she…

C3is Inc. Announces Reverse Stock Split

C3is Inc. Announces Reverse Stock Split

C3is Inc., a ship-owning company providing dry bulk and crude oil transportation services, announced a 1-for-7 reverse stock split effective April 27, 2026. The move aims to increase the market price of the company's shares to meet Nasdaq's minimum bid price requirements and avoid delisting. The split will reduce outstanding shares from approximate…